Atopic dermatitis (AD) is a chronic relapsing, noncontagious skin inflammation characterized by dry skin and itch. Mutation in filaggrin gene leads to defective skin barrier, allowing entry of allergen and eliciting immunological response.
Objectives
The aims of this study were to investigate the prevalence of AD in Malaysian children and to understand the pattern of drug therapy. Such information could be useful to establish the relationship between ethnicity and family history of atopy and the development of associated signs and symptoms.
Methods
A cross-sectional survey was conducted among children attending kindergartens and nurseries. Standardized questionnaires were filled out by parents.
Results
Overall prevalence of AD was 13.4%. Of 384 participants recruited, the highest prevalence was observed in males, Malays, participants younger than 2 years, and those with atopic background such as asthma, hay fever, and family history of atopic diseases. Calamine and white soft paraffin were the preferred choice of nonprescription drugs, whereas topical hydrocortisone seemed to be the preferred choice of prescription drug in the management of AD.
Conclusions
The overall prevalence is comparable to that reported in the International Study of Asthma and Allergies in Childhood Phase One. There is an association between ethnicity and AD prevalence. Topical corticosteroids and emollients are the mainstay of AD management among Malaysians.
Get full access to this article
View all access options for this article.
References
1.
WilliamsHC.Clinical practice. Atopic dermatitis. N Engl J Med, 2005; 352(22):2314–2366.
WilliamsH, RobertsonC, StewartA, et al.Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol, 1999; 103(1):125–138.
5.
HoareC, Li Wan PoA, WilliamsH. Systematic review of treatments for atopic eczema. Health Technol Assess, 2000; 4(37):1–191.
6.
MevorahB, FrenkE, WietlisbachV, et al.Minor clinical features of atopic dermatitis. Evaluation of their diagnostic significance. Dermatology, 1988; 177(6):360–364.
7.
HaileamlakA, LewisSA, BrittonJ, et al. Validation of the International Study of Asthma and Allergies in Children (ISAAC) andU.K. criteria for atopic eczema in Ethiopian children. Br J Dermatol, 2005; 152(4):735–741.
8.
DeD, KanwarAJ, HandaS. Comparative efficacy of Hanifin and Rajka's criteria and the UK Working Party's diagnostic criteria in diagnosis of atopic dermatitis in a hospital setting in North India. J Eur Acad Dermatol Venereol, 2006; 20:853–859.
9.
SamochockiZ, DejewskaJ. A comparison of criteria for diagnosis of atopic dermatitis in children. World J Pediatr, 2012; 8(4):355–358.
10.
HanifinJM, RajkaG. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl, 1980; 60(92):44–7.
11.
QuahBS, Wan-PauziI, AriffinN, et al.Prevalence of asthma, eczema and allergic rhinitis: two surveys, 6 years apart, in Kota Bharu, Malaysia. Respirology, 2005; 10(2):244–249.
12.
JaafarRB, PettitJH. Atopic eczema in a multiracial country (Malaysia). Clin Exp Dermatol, 1993; 18(6):496–499.
13.
ScariaSEJ, DharmaratnamAD. Epidemiology and treatment pattern of atopic dermatitis in patients attending a tertiary care teaching hospital. Int J Res Pharm Sci, 2011; 2(1):38–44.
14.
GiriVP, GiriOP, KanodiaS, et al.Prescription pattern in atopic dermatitis in skin outpatients in a tertiary care teaching hospital at Darbhanga, Bihar, India. Int J Sci Study, 2014; 2(18):10–13.
15.
BaronED, BarzilaiD, JohnstonG, et al.Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan, U.S.A. and U.K. Br J Dermatol, 2002; 147(4):710–715.
16.
RubelD, ThirumoorthyT, SoebaryoRW, et al.Consensus guidelines for the management of atopic dermatitis: an Asia-Pacific perspective. J Dermatol, 2013; 40(3):160–171.
17.
Schultz-LarsenF, DiepgenT, SvenssonA. The occurrence of atopic dermatitis in north Europe: an international questionnaire study. J Am Acad Dermatol, 1996; 34(5 pt 1):760–764.
18.
LaughterD, IstvanJA, TofteSJ, et al.The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol, 2000; 43(4):649–655.
19.
KuhnyarA, EgyudK, SzaboI, et al.Prevalence of atopic dermatitis among children under 19 in an East-Hungarian agricultural county. Clin Dev Immunol, 2006; 13(2–4):395–399.
20.
BrenninkmeijerEE, SchramME, LeeflangMM, et al.Diagnostic criteria for atopic dermatitis: a systematic review. Br J Dermatol, 2008; 158:754–765.
ZuberbierT, OrlowSJ, PallerAS, et al.Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol, 2006; 118(1):226–232.
23.
HarrisJM, WilliamsHC, WhiteC, et al.Early allergen exposure and atopic eczema. Br J Dermatol, 2007; 156(4):698–704.
24.
Ben-GashirMA, SeedPT, HayRJ. Predictors of atopic dermatitis severity over time. J Am Acad Dermatol, 2004; 50(3):349–356.
25.
ShawTE, CurrieGP, KoudelkaCW, et al.Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol, 2011; 131(1):67–73.
26.
HongS, SonDK, LimWR, et al.The prevalence of atopic dermatitis, asthma, and allergic rhinitis and the comorbidity of allergic diseases in children. Environ Health Toxicol, 2012; 27:e2012006.
27.
KayJ, GawkrodgerDJ, MortimerMJ, et al.The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol, 1994; 30(1):35–39.
28.
GeradaE, Agius MuscatH, CamilleriL, et al.Gender differences in the prevalence and severity of wheezing, rhinitis and eczema in 5- to 8-year old and 12- to 15-year old Maltese children (ISAAC-Malta). Eur Respir J, 2015; 46(suppl 59): PA1337.
29.
RonaRJ, Duran-TauleriaE, ChinnS. Family size, atopic disorders in parents, asthma in children, and ethnicity. J Allergy Clin Immunol, 1997; 99(4):454–460.
30.
JanumpallySR, FeldmanSR, GuptaAK, et al.In the United States, blacks and Asian/Pacific Islanders are more likely than whites to seek medical care for atopic dermatitis. Arch Dermatol, 2002; 138(5):634–637.
31.
WilliamsHC, PembrokeAC, ForsdykeH, et al.London-born black Caribbean children are at increased risk of atopic dermatitis. J Am Acad Dermatol, 1995; 32(2 pt 1):212–217.
32.
KayserM, BrauerS, SchädlichH, et al. Y Chromosome STR haplotypes and the genetic structure of U.S. populations of African, European, and Hispanic ancestry. Genome Res, 2003; 13(4):624–634.
33.
SilverbergJI.Racial and ethnic disparities in atopic dermatitis. Curr Dermatol Rep, 2015; 4(1):44–48.
34.
SherriffA, Golding J; Alspac StudyTeam. Hygiene levels in a contemporary population cohort are associated with wheezing and atopic eczema in preschool infants. Arch Dis Child, 2002; 87(1):26–29.
35.
HopperJL, BuiQM, ErbasB, et al.Does eczema in infancy cause hay fever, asthma, or both in childhood? Insights from a novel regression model of sibling data. J Allergy Clin Immunol, 2012; 130(5):1117.e1–1122.e1.
36.
Esparza-GordilloJ, MatanovicA, MarenholzI, et al.Maternal filaggrin mutations increase the risk of atopic dermatitis in children: an effect independent of mutation inheritance. PLoS Genet, 2015; 11(3):e1005076.
37.
BöhmeM, WickmanM, Lennart NordvallS, et al.Family history and risk of atopic dermatitis in children up to 4 years. Clin Exp Allergy, 2003; 33(9):1226–1231.
38.
EkbäckM, TednerM, DevenneyI, et al.Severe eczema in infancy can predict asthma development. A prospective study to the age of 10 years. PLoS One, 2014; 9(6):e99609.
39.
BurgessJA, DharmageSC, ByrnesGB, et al.Childhood eczema and asthma incidence and persistence: a cohort study from childhood to middle age. J Allergy Clin Immunol, 2008; 122(2):280–285.
40.
JunaidiAB, FauziR, GhazaliAS. Ethnic politics in Kuala Lumpur: a post-2013 GE perception study of voters residing in People's Housing Schemes. Malay J Soc Space, 2015; 11(7):33–44.
41.
Putrajaya PPN WPKL [Federal Territory Election Office of Kuala Lumpur]. Bahagian Parlimen [April 20, 2017]. Available at: http://ppn.spr.gov.my/kualalumpur/?page_id=1548. Accessed January21, 2018.
42.
CochranWG.Sampling Techniques. 3rd ed. New York: John Wiley & Sons;. 1977.
43.
KrejcieRV, MorganDW. Determining sample size for research activities. Educ Psychol Meas, 1970; 30(3):607–10.
44.
Wadonda-KabondoN, SterneJA, GoldingJ, et al.Association of parental eczema, hayfever, and asthma with atopic dermatitis in infancy: birth cohort study. Arch Dis Child, 2004; 89(10):917–21.
45.
FergussonDM, HorwoodLJ, ShannonFT, et al.Early solid feeding and recurrent childhood eczema: a 10-year longitudinal study. Pediatrics, 1990; 86(4):541–546.
46.
CarrollCL, BalkrishnanR, FeldmanSR, et al.The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol, 2005; 22(3):192–199.
47.
World Health Organization (WHO). WHO Model Prescribing Information: Drug Used in Skin Diseases. Geneva, Switzerland: World Health Organization; 1997.
48.
SaavedraJM, BoguniewiczM, ChamlinS, et al.Patterns of clinical management of atopic dermatitis in infants and toddlers: a survey of three physician specialties in the United States. J Pediatr, 2013; 163(6):1747–1753.
49.
AbrahamMS, SreejaPA, AbrahamBT. Prescribing pattern of corticosteroids and cost effective analysis of clobetasol and fluticasone for eczema in a tertiary care teaching hospital at Palakkad, Kerala. Int J Pharm Pharm Res, 2016; 6(3):67–77.
50.
AlexanderT, MaximE, CardwellLA, et al. Prescriptions for atopic dermatitis: oral corticosteroids remain commonplace. J Dermatol Treat, 2017(28):1–10.
51.
SarkarC, SripathiH. Drug prescribing pattern in dermatology in a teaching hospital in western Nepal. J Nepal Med Assoc, 2001; 41:241–246.
52.
PathakAK, KumarS, KumarM, et al.Study of drug utilization pattern for skin diseases in dermatology OPD of an Indian tertiary care hospital—a prescription survey. J Clin Diagn Res, 2016; 10(2):FC01–FC05.
53.
HongJ, BuddenkotteJ, BergerTG, et al.Management of itch in atopic dermatitis. Semin Cutan Med Surg, 2011; 30(2):71–86.
